Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Oklahoma City, OK Metro Edition
Focus: LIFE SCI
4.2%
Metro unemployment rate
Up ~1 pt YoY; ends 52-month streak below 4%
$77,407 metro
Regulatory Affairs Specialist pay
vs $104,000 national median, metro down significantly
-1.5%
Metro manufacturing employment
vs +0.7% statewide manufacturing growth
33%+
Oklahoma firms freezing wages
Up from 15% in 2023 (KC Fed survey)
This Month's Takeaways
Metro advertised pay for Regulatory Affairs Specialists dropped significantly even as national postings hold at $104,000 and VP-level regulatory talent commands $320K-$580K amid EU MDR and FDA pathway pressures. Local employers risk losing mid-career regulatory professionals to remote roles at better-resourced coastal biopharma firms.
Metro CRA pay at $108,075 sits well above the $90,956 national median, both trending up, signaling genuine local demand tightness for clinical operations talent tied to active trial activity. This divergence is worth benchmarking against sponsor and CRO pipeline activity before assuming it reflects broader metro wage strength.
Metro manufacturing employment fell 1.5% against a backdrop of statewide manufacturing growth of just 0.7%, with most Oklahoma firms not planning headcount increases in 2026. CDMO and biomanufacturing operators should treat current quality and operations staff as difficult to backfill, raising the retention stakes for any planned attrition.
Over a third of Oklahoma firms now report no plans to raise wages in 2026, up sharply from 15% in 2023, a constraint that collides directly with biotech's need to compete nationally for PhD-level scientists earning $35-$50/hour in protein characterization roles. Organizations anchored to state wage norms risk falling further behind specialty talent markets.
Local Labor Conditions
Oklahoma City metro unemployment climbed to 4.2% in September, nearly a full point above year-ago levels, as manufacturing contracts 1.5% and professional/business services shed positions, ending the metro's 52-month streak of sub-4% readings. Life sciences employers are hiring into a cooling but not slack market, where specialized scientific and regulatory talent remains scarce even as general labor market softness gives employers more leverage on entry-level and administrative roles.
Leadership & Talent Implications
Metro-level softening masks a bifurcated reality: Regulatory Affairs Specialist pay has fallen significantly here even as national demand holds steady near $104,000, suggesting local employers are either under-leveling roles or losing ground in a national bidding war for compliance-critical talent. Clinical Data Manager pay is down both locally and nationally, which may reflect increased outsourcing of data management functions to CROs rather than genuine demand softness — a distinction that changes the build-vs-outsource calculus. Consider reviewing whether Regulatory Affairs compensation structures reflect true scarcity value or have drifted below the threshold needed to retain credentialed talent against remote-eligible national competitors.
Advertised Pay Indicators
| Role | P25 | Median | P75 | Local Trend | National | Nat. Trend |
|---|---|---|---|---|---|---|
| Research Scientist | $93,305 | $109,700 | $130,980 | ↑ Significant increase | $131,354 | ↑ Significant increase |
| Clinical Research Associate | $62,400 | $108,075 | $123,306 | ↑ Significant increase | $90,956 | ↑ Significant increase |
| Lab Technician | $37,350 | $38,480 | $40,087 | ↑ Significant increase | $47,402 | ↓ Moderate decline |
| Regulatory Affairs Specialist | $66,242 | $77,407 | $83,823 | ↓ Significant decline | $104,000 | → Stable |
| Clinical Data Manager | $94,907 | $112,078 | $115,362 | ↓ Significant decline | $123,031 | ↓ Moderate decline |
| Biostatistician | $94,264 | $141,004 | $143,050 | → Stable | $133,322 | ↑ Moderate increase |
| Validation Engineer | — | — | — | — No data | $108,377 | ↑ Moderate increase |
Some roles reflect state-level data where local metro sample size was insufficient.
Looking Ahead · Next 30–60 Days
Emerging pressure point
Watch whether Oklahoma City's rising unemployment rate (4.2%, up nearly a point year-over-year) begins delivering displaced professional-services and manufacturing talent into adjacent life sciences support roles over the next two months.
Worth watching
National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions, not execution roles — monitor whether any affected talent relocates to Oklahoma CDMO or specialty pharma employers given lower cost of living.
Potential inflection point
Regulatory Affairs Specialist pay compression locally, against national stability, may trigger visible attrition at the mid-career level over Q4 if competitors outside the metro continue recruiting remotely.
Early indicator
Continued state-level softening in wage-increase intentions heading into 2026 budget cycles could sharpen the build-vs-outsource decision for quality and regulatory functions, as internal pay flexibility narrows relative to CRO/CDMO contract rates.
WageScape Member Benefit
Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.
Pulse Plus
3 metro reports
$149/year
Pulse Pro
10 metro reports
$349/year
Enterprise
10+ markets
Contact us
WageTrak · 15% Member Discount
On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.
Forwarded This Briefing?
Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.